Arrowhead Pharmaceuticals, Inc.: Baptista Research downgrades to buy from hold with a price target reduced from USD 30 to USD 28.90.
Assurant, Inc.: Piper Sandler & Co downgrades to neutral from overweight with a target price of USD 200.
Capri Holdings Limited: Baptista Research downgrades t…
© MarketScreener.com 2024
Assurant, Inc.: Piper Sandler & Co downgrades to neutral from overweight with a target price of USD 200.
Capri Holdings Limited: Baptista Research downgrades t…
© MarketScreener.com 2024